PI3K / Akt / mTOR
-
CAL-130 Racemate
Catalog No. A20942 PI3Kδ inhibitorCAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor. 了解更多 -
Alpelisib hydrochloride
Catalog No. A21794 PI3Kα inhibitorAlpelisib hydrochloride (BYL-719 hydrochloride) is a potent, orally active, and selective PI3Kα inhibitor with IC50s of 5 nM, 250 nM, 290 nM and 1200 nM for p110α, p110γ, p110δ, and p110β, respectively. 了解更多 -
Umbralisib R-enantiomer
Catalog No. A21993 PI3Kδ inhibitorUmbralisib R-enantiomer (TGR-1202 R-enantiomer) is a PI3Kδ inhibitor, which is the less active enantiomer of TGR-1202. 了解更多 -
GSK2292767
Catalog No. A16564 PI3Kδ inhibitorGSK2292767 is a potent and selective inhibitor of phosphatidylinositol 3-kinase δ (PI3Kδ; Ki = 79 pM). GSK2292767 is >100-fold selective for PI3Kδ over a panel of 250 kinases. 了解更多 -
PI3Kdelta inhibitor 1
Catalog No. A19249 PI3Kδ inhibitorPI3Kdelta inhibitor 1 (Compound 5d) is a potent, selective and orally available PI3Kδ inhibitor with an IC50 of 1.3 nM. 了解更多 -
CHMFL-PI3KD-317
Catalog No. A19990 PI3Kδ inhibitorCHMFL-PI3KD-317 is a highly potent, selective and orally active PI3Kδ inhibitor, with an IC50 of 6 nM. 了解更多 -
Everolimus (RAD001)
Catalog No. A10374 mTOR 抑制剂Everolimus (RAD001)是西罗莫司的40-O-(2-羟乙基)衍生物,与西罗莫司作为mTOR抑制剂的作用相似。 了解更多 -
Rapamycin (Sirolimus)
Catalog No. A10782 mTOR 抑制剂Rapamycin (Sirolimus)是通过抑制T细胞和B细胞对白介素2(IL-2)的反应来防止其活化。 了解更多 -
Torin 1
Catalog No. A11587 -
PP242 (Torkinib)
Catalog No. A10746 mTOR 抑制剂PP242 (Torkinib)在mTORC1和mTORC2中都是有效的选择性mTOR抑制剂。 了解更多 -
FK-506 (Tacrolimus)
Catalog No. A10389 mTOR 抑制剂FK-506 (Tacrolimus)是一种免疫抑制药物,通过结合到抑免蛋白FKBP12 (FK506 结合蛋白)产生新的复合物,从而降低T细胞中肽酰脯氨酰异构酶活性。 了解更多 -
AZD2014 (Vistusertib)
Catalog No. A11303 mTORC1/2 抑制剂Vistusertib (AZD2014)是一种新型mTOR抑制剂,无细胞试验中IC50为2.8 nM;对多种PI3K亚型(α/β/γ/δ)具有较高选择性。浓度为1 μM时,对大多数激酶无或有微弱结合力。 了解更多 -
mTOR inhibitor (mTOR-IN-1)
Catalog No. A15175 -
MHY1485
Catalog No. A15508 -
Temsirolimus (Torisel)
Catalog No. A10906 -
KU-0063794
Catalog No. A10505 -
WYE-125132 (WYE-132)
Catalog No. A11038 mTOR 抑制剂WYE-125132 (WYE-132)是一种高度有效的,ATP竞争性的mTOR抑制剂,IC50为0.19 nM;作用于mTOR比作用于PI3Ks或PI3K相关激酶hSMG1和ATR选择性高。 了解更多 -
OSI-027
Catalog No. A11056 -
Deforolimus (Ridaforolimus)
Catalog No. A10295 mTOR 抑制剂Deforolimus (Ridaforolimus)是mTOR蛋白的研究目标靶向小分子抑制剂。阻断mTOR通过干扰细胞生长,分裂,代谢和血管生成,在癌细胞中产生饥饿样的效应。 了解更多 -
INK 128 (MLN0128)
Catalog No. A11461 mTOR 抑制剂INK 128是TORC1/2抑制剂,也是具有潜在抗肿瘤活性的猛禽mTOR(TOR复合物1或TORC1)和raptor-mTOR(TOR复合物2或TORC2)的口服生物利用抑制剂。 了解更多 -
Zotarolimus
Catalog No. A11950 mTOR 抑制剂Zotarolimus是一种免疫抑制剂,可以抑制FKBP-12结合的IC50为2.8nM。。它是雷帕霉素的半合成衍生物。它设计用于以磷酸胆碱为载体的支架。 了解更多 -
XL388
Catalog No. A12395 -
CC-115
Catalog No. A15779 -
mTOR inhibitor-2
Catalog No. A13035 mTOR inhibitormTOR inhibitor-2 is a highlt potent, selective and oral mTOR inhibitor with an IC50 of 7 nM. mTOR inhibitor-2 inhibits cellular phosphorylation of mTORC1 (pS6 and p4E-BP1) and mTORC2 (pAKT (S473)) substrates. 了解更多 -
HDACs/mTOR Inhibitor 1
Catalog No. A13462 HDACs/mTOR Inhibitor 1HDACs/mTOR Inhibitor 1 is a dual Histone Deacetylases (HDACs) and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies. 了解更多 -
42-(2-Tetrazolyl)rapamycin
Catalog No. A21394 mTOR inhibitor42-(2-Tetrazolyl)rapamycin is a prodrug compound of a rapamycin analog extracted from patent US 20080171763 A1, Example 1. Rapamycin is a specific mTOR inhibitor. 了解更多 -
PDK1 inhibitor
Catalog No. A11528 -
PDK1 inhibitor
Catalog No. A16185 PDK1 抑制剂PDK1 inhibitor,强效,ATP竞争性和选择性双重PI3K和PDPK1抑制剂(PDK1和p-T308-PKB抑制的IC50值分别为34 nM和94 nM。 了解更多 -
GSK 2334470
Catalog No. A12767